Rheumatoid Arthritis
News from the FDA/CDC
Second FDA-Approved Tocilizumab Biosimilar Has Intravenous, Subcutaneous Formulations
It’s unclear when the new tocilizumab products will be commercially available.
Conference Coverage
Leflunomide: A Fresh Look at an Old Drug
Overlooked in the biologic era, it still has a place.
From the Journals
New Biomarkers Identified to Help Predict Cardiovascular Risk in RA
Adding these biomarkers to clinical variables better predicted increases in arterial inflammation than clinical indices such as the Framingham...
From the Journals
DMARDs Restore GI Microbiota Balance in RA But Ability to Predict Response Falls Short
An observational study in the United Kingdom found that patients with RA who started taking antirheumatic drugs had changes in their microbiome...
News from the FDA/CDC
FDA Approves 10th Humira Biosimilar, With Interchangeability
Adalimumab-ryvk (Simlandi) is the first adalimumab biosimilar in a high-concentration formulation to receive interchangeability status from the...
From the Journals
What Markers Are Helpful to Diagnose Infection in Tocilizumab Users?
The discriminating capacity of certain routinely obtained cell count and protein biomarkers distinguished infected and noninfected adults with...
From the Journals
Autoimmune Disease Risk May Rise Following Cushing Disease Remission After Surgery
The findings suggested the need for closer postsurgical monitoring of patients with a family history of autoimmune disease.
From the Journals
Comorbidities and Disease Type Weigh Heavily in Pregnancy Outcomes of Immune-Mediated Inflammatory Diseases
After controlling for other chronic conditions, certain immune-mediated inflammatory diseases were not associated with an increased risk for poor...
Latest News
Breaking the Diagnostic Bottleneck in RA
RA diagnosis can be challenging, but technology may speed the process, and help patients receive treatment earlier.
From the Journals
A Paradox? Higher Male Fertility Seen With Inflammatory Arthritis
In a population-based study, male patients with inflammatory joint disease had more children and were less likely to be childless than were...
From the Journals
Is RA Disease Activity Assessed Too Little After Starting TNFi?
More than half of patients with RA lacked baseline assessment of disease when they began TNFi therapy.